Track topics on Twitter Track topics that are important to you
ATLANTA, GA / ACCESSWIRE / April 12, 2018 / NeurOp, Inc., a clinical-stage biotechnology company, today announced the initiation of a Phase 1 clinical trial of NP10679, a highly potent and select...
NeurOp, Inc. is an Atlanta-based biopharmaceutical company developing new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia (stroke)...
We have published hundreds of NeurOp, Inc. news stories on BioPortfolio along with dozens of NeurOp, Inc. Clinical Trials and PubMed Articles about NeurOp, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeurOp, Inc. Companies in our database. You can also find out about relevant NeurOp, Inc. Drugs and Medications on this site too.
Depression is a serious mental health condition, where sad feelings carry on for weeks or months and interfere with your life. The symptoms include feeling unhappy most of the time (but may feel a little better in the evenings), loosing interest in lif...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...